financetom
Business
financetom
/
Business
/
Exclusive-Jamie Dimon charts JPMorgan expansion plan into Africa
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Jamie Dimon charts JPMorgan expansion plan into Africa
Oct 17, 2024 1:12 PM

NEW YORK (Reuters) - JPMorgan Chase ( JPM ), the largest U.S. lender, plans to enter Kenya and Ivory Coast this year and grow its footprint in Africa, CEO Jamie Dimon told Reuters.

International markets are a growth area for JPMorgan ( JPM ), which has more than $4.2 trillion in assets and operates in over 100 countries. That compares with Citigroup ( C/PN ), which does business in almost 180 countries and has the largest global footprint among U.S. banking giants.

"We want to add a country or two (enter or deepen presence) in Africa, every couple of years or so," Dimon said by phone from New York on Friday before departing on a trip to Africa. The countries and pace of expansion have not previously been reported.

Dimon will hold meetings in Kenya, Nigeria and South Africa on the tour, Reuters reported last month.

"This will allow us to be on the ground in these countries which gives you a lot more local knowledge and relationships," Dimon said.

"And when you do it, you basically will cover the government, maybe some big government enterprises and the multinationals that are going in there with traditional banking services," he added.

In Kenya and Ivory Coast, the bank will focus on commercial and investment banking, treasury services, and possibly some lending, Dimon said. In those two countries, it has no immediate plans to offer asset and wealth management (AWM) services, which are already available in South Africa and Nigeria.

"We are not doing AWM now but that doesn't mean it wouldn't happen in the next few years," Dimon said.

JPMorgan's ( JPM ) earlier aspirations to enter Ghana and Kenya in the last several year were thwarted by regulators, according to media reports.

On Monday, the Central Bank of Kenya said it authorized JPMorgan ( JPM ) to establish a representative office there.

In the past, "the U.S. government was not very keen on banks expanding into different geographies, as this was just after the financial crisis," Dimon said noting the U.S. is now more supportive.

It is a positive move if U.S. financial institutions expand abroad, and the government should support such endeavors to compete overseas, he said, citing the broad footprint of Chinese companies and saying that U.S. companies should also be in these places.

Major global lenders have adopted differing strategies for individual sub-Saharan markets, targeting the fastest-growing areas while seeking to distinguish themselves from local and regional competitors.

For instance, Standard Chartered ( SCBFF ) has focused on Kenya. Its assets under management in the East African nation grew by a quarter last year to 185.5 billion Kenyan shillings ($1.4 billion), it said.

The expansion may not have a material impact on JPMorgan's ( JPM ) business in the near term, but it will be beneficial for the company and future leaders in the long run, Dimon said.

JPMorgan ( JPM ) is among the top five international private banks by assets under supervision.

In the last five years, about 700 bankers have been involved in expanding into 27 new locations worldwide, generating $2 billion in revenue for its commercial and investment bank, executives told investors in May.

(Reporting by Nupur Anand in New York, additional reporting by Hereward Holland, David Lewis and Duncan Miriri in Nairobi, editing by Lananh Nguyen and Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LB Pharmaceuticals raises $285 million in US IPO
LB Pharmaceuticals raises $285 million in US IPO
Sep 10, 2025
(Reuters) -LB Pharmaceuticals raised $285 million in its U.S. initial public offering, the biotech firm said on Wednesday, marking the first sizable biotech IPO since February. The New York-based firm sold 19 million shares at $15 each, within its marketed range of $14 to $16 apiece. The IPO valued LB at $301.5 million. Companies ranging from crypto to consumer are...
AIRO Announces Pricing of Upsized Public Offering of Common Stock
AIRO Announces Pricing of Upsized Public Offering of Common Stock
Sep 10, 2025
ALBUQUERQUE, N.M. & MONTREAL & STØVRING, Denmark & WASHINGTON--(BUSINESS WIRE)-- AIRO Group Holdings, Inc. ( AIRO ) , a company specializing in advanced aerospace and defense technologies, today announced the pricing of its upsized underwritten public offering of 4,200,000 shares of its common stock at a public offering price of $18.50 per share. The gross proceeds to AIRO ( AIRO...
LB Pharmaceuticals raises $285 million in US IPO
LB Pharmaceuticals raises $285 million in US IPO
Sep 10, 2025
Sept 10 (Reuters) - LB Pharmaceuticals raised $285 million in its U.S. initial public offering, the biotech firm said on Wednesday, marking the first sizable biotech IPO since February. ...
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
Sep 10, 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial public offering of 19,000,000 shares of its common stock at a public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from the offering are expected to be $285.0 million before deducting underwriting discounts and commissions...
Copyright 2023-2026 - www.financetom.com All Rights Reserved